Morlat P - Search Results

1

Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study.

Kamara DA, Ryom L, Ross M, Kirk O, Reiss P, Morlat P, Moranne O, Fux CA, Mocroft A, Sabin C, Lundgren JD, Smith CJ; D:A:D study Group. Kamara DA, et al. Among authors: morlat p. BMC Nephrol. 2014 Mar 25;15:51. doi: 10.1186/1471-2369-15-51. BMC Nephrol. 2014. PMID: 24666792 Free PMC article.

2

Adhesive capsulitis of the shoulder in an HIV patient treated with nelfinavir.

de Witte S, Bonnet F, Bonarek M, Lamarque P, Morlat P, Receveur MC, Beylot J. de Witte S, et al. Among authors: morlat p. AIDS. 2002 Jun 14;16(9):1307-8. doi: 10.1097/00002030-200206140-00023. AIDS. 2002. PMID: 12045506 No abstract available.

3

Rhabdomyolysis as a consequence of adrenal insufficiency.

de Witte SA, Bonnet F, Morlat P, Beylot J. de Witte SA, et al. Among authors: morlat p. Am J Med. 2003 Feb 1;114(2):160. doi: 10.1016/s0002-9343(02)01319-0. Am J Med. 2003. PMID: 12586241 No abstract available.

4

Time-updated CD4+ T lymphocyte count and HIV RNA as major markers of disease progression in naive HIV-1-infected patients treated with a highly active antiretroviral therapy: the Aquitaine cohort, 1996-2001.

Thiébaut R, Chêne G, Jacqmin-Gadda H, Morlat P, Mercié P, Dupon M, Neau D, Ramaroson H, Dabis F, Salamon R; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine. Thiébaut R, et al. Among authors: morlat p. J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):380-6. doi: 10.1097/00126334-200307010-00013. J Acquir Immune Defic Syndr. 2003. PMID: 12843750

5

Hepatitis C virus genetic variability in 52 human immunodeficiency virus-coinfected patients.

Neau D, Jouvencel AC, Legrand E, Trimoulet P, Galperine T, Chitty I, Ventura M, Le Bail B, Morlat P, Lacut JY, Ragnaud JM, Dupon M, Fleury H, Lafon ME. Neau D, et al. Among authors: morlat p. J Med Virol. 2003 Sep;71(1):41-8. doi: 10.1002/jmv.10451. J Med Virol. 2003. PMID: 12858407 Clinical Trial.

6

Prevalence of cryoglobulinemia and serological markers of autoimmunity in human immunodeficiency virus infected individuals: a cross-sectional study of 97 patients.

Bonnet F, Pineau JJ, Taupin JL, Feyler A, Bonarek M, de Witte S, Bernard N, Lacoste D, Morlat P, Beylot J. Bonnet F, et al. Among authors: morlat p. J Rheumatol. 2003 Sep;30(9):2005-10. J Rheumatol. 2003. PMID: 12966606

7

Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.

Bonnet F, Balestre E, Thiébaut R, Morlat P, Pellegrin JL, Neau D, Dabis F; Groupe d'Epidemiologie Clinique du SIDA en Aquitaine. Bonnet F, et al. Among authors: morlat p. Clin Infect Dis. 2006 Feb 1;42(3):411-7. doi: 10.1086/499054. Epub 2005 Dec 27. Clin Infect Dis. 2006. PMID: 16392091

8

An additive/subtractive genotypic score as a determinant of the virological response to didanosine in HIV-1 infected patients.

Capdepont S, Aurillac-Lavignolle V, Faure M, Dupon M, Morlat P, Ragnaud JM, Chêne G, Fleury H, Masquelier B; GECSA. Capdepont S, et al. Among authors: morlat p. J Clin Virol. 2006 May;36(1):36-42. doi: 10.1016/j.jcv.2006.01.008. Epub 2006 Feb 28. J Clin Virol. 2006. PMID: 16513416

9

Pravastatin in HIV-infected patients treated with protease inhibitors: a placebo-controlled randomized study.

Bonnet F, Aurillac-Lavignolle V, Breilh D, Thiébaut R, Peuchant E, Bernard N, Lacoste D, Dabis F, Beylot J, Chêne G, Morlat P; GECSA. Bonnet F, et al. Among authors: morlat p. HIV Clin Trials. 2007 Jan-Feb;8(1):53-60. doi: 10.1310/hct0801-53. HIV Clin Trials. 2007. PMID: 17434849 Clinical Trial.

10

HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population.

Lewden C, Chene G, Morlat P, Raffi F, Dupon M, Dellamonica P, Pellegrin JL, Katlama C, Dabis F, Leport C; Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS) CO8 APROCO-COPILOTE Study Group; Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS) CO3 AQUITAINE Study Group. Lewden C, et al. Among authors: morlat p. J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):72-7. doi: 10.1097/QAI.0b013e318134257a. J Acquir Immune Defic Syndr. 2007. PMID: 17621240 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

464 results

Search Page

Filters